Strategro International, LLC, a North American market entry and business growth firm, recently presented key findings and conclusions of their Assessment of the Icelandic Biotech System to Icelandic industry and government officials. The assessment, described as a constructive critique of the systems, resources, and infrastructure necessary to generate and support biotech start-ups in Iceland, was funded by the Minister of Fisheries’ AVS Fund, and intended to identify weaknesses and strengths in the current system. The report suggests ways to kick-start innovation and entrepreneurship in the biotech sector so that Iceland is better positioned for the future. According to the assessment, Iceland could be considered an emerging biotech cluster today, but is now facing a crossroad for accelerating development of its biotech industry.>>> Discuss This Story
